Načítá se...
4CPS-183 Off-label rituximab in neurology patients
BACKGROUND: Rituximab is an anti-CD20 monoclonal antibody. Its off-label use has increased in the management of a variety of neurologic diseases. PURPOSE: To describe rituximab prescriptions in the Neurology Department, and evaluate the scientific evidence in off-label indications to rationalise its...
Uloženo v:
| Vydáno v: | Eur J Hosp Pharm |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535240/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.273 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|